Karmanos Cancer Institute at McLaren Flint

Flint, Michigan 48532

6 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumor, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage IIIA, HER2-negative Breast Cancer, Hepatocellular Carcinoma Recurrent, Hormone Receptor Positive Tumor, Malignant Ovarian Epithelial Tumor, Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma

Studies at this site

• Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer — Recruiting now
• Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies — Recruiting now
• ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer — Recruiting now
• A Study of the TheraBionic P1 Device in Breast Cancer — Recruiting now
• TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma — Recruiting now
• Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer — Recruiting now
• Ask Questions (ASQ):Implementation of a Communication Intervention — Completed